Files and links (1)
Published, Version of Record (VoR)Open Access (License Unspecified), Open
Journal article
Endometrial Cancers Harboring Mutated Fibroblast Growth Factor Receptor 2 Protein Are Successfully Treated With a New Small Tyrosine Kinase Inhibitor in an Orthotopic Mouse Model
International journal of gynecological cancer, v 28(1), pp 152-160
26 Sep 2017
PMCID: PMC5735020
PMID: 28953502
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Supplemental digital content is available in the text.
Metrics
Details
- Title
- Endometrial Cancers Harboring Mutated Fibroblast Growth Factor Receptor 2 Protein Are Successfully Treated With a New Small Tyrosine Kinase Inhibitor in an Orthotopic Mouse Model
- Creators
- Sebastien Taurin - University of UtahChieh-Hsiang Yang - University of UtahMaria Reyes - University of UtahSungpil Cho - University of UtahDemetrius M. Coombs - Drexel UniversityElke A. Jarboe - University of UtahTheresa L. Werner - Huntsman Cancer InstituteC. Matthew Peterson - University of UtahMargit M. Janát-Amsbury - University of UtahBeverly A Reyes - Pharmacology and Physiology
- Publication Details
- International journal of gynecological cancer, v 28(1), pp 152-160
- Publisher
- Lippincott Williams & Wilkins
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Pharmacology and Physiology
- Web of Science ID
- WOS:000419460600021
- Scopus ID
- 2-s2.0-85040228060
- Other Identifier
- 991019184822404721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- Web of Science research areas
- Obstetrics & Gynecology
- Oncology